{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:55:27Z","timestamp":1781661327467,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373465"],"award-info":[{"award-number":["82373465"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573965"],"award-info":[{"award-number":["82573965"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jtauto.2026.100365","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T07:54:37Z","timestamp":1773474877000},"page":"100365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Machine learning for predicting macrophage activation syndrome in adult patients with Still's disease"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7195-8497","authenticated-orcid":false,"given":"Yihe","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7221-5084","authenticated-orcid":false,"given":"Changyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zile","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuni","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3386-297X","authenticated-orcid":false,"given":"Jianjun","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jtauto.2026.100365_bib1","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1136\/ard-2024-225851","article-title":"EULAR\/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease","volume":"83","author":"Fautrel","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2026.100365_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41584-023-01065-6","article-title":"Recent advances and evolving concepts in Still's disease","volume":"20","author":"Ruscitti","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jtauto.2026.100365_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/art.43052","article-title":"Macrophage activation syndrome","volume":"77","author":"Nigrovic","year":"2025","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.jtauto.2026.100365_bib4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/08998280.2025.2482315","article-title":"Macrophage activation syndrome-associated adult onset still disease treatment: a scoping review of case reports and case series","volume":"38","author":"Chaisrimaneepan","year":"2025","journal-title":"Proc. - Bayl. Univ. Med. Cent."},{"key":"10.1016\/j.jtauto.2026.100365_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.autrev.2016.09.016","article-title":"Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: analysis of 41 cases collected in 2 rheumatologic centers","volume":"16","author":"Ruscitti","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2026.100365_bib6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12916-016-0738-8","article-title":"Adult-onset still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers","volume":"14","author":"Ruscitti","year":"2016","journal-title":"BMC Med."},{"key":"10.1016\/j.jtauto.2026.100365_bib7","first-page":"977","article-title":"Characteristics of 21 patients with secondary hemophagocytic lymphohistiocytosis-insights from a single-center retrospective study","volume":"61","author":"Dziedzic","year":"2025","journal-title":"Med Kaunas Lith"},{"key":"10.1016\/j.jtauto.2026.100365_bib8","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s11739-023-03408-3","article-title":"Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA network Still's Disease registry","volume":"18","author":"Triggianese","year":"2023","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.jtauto.2026.100365_bib9","doi-asserted-by":"crossref","first-page":"6219","DOI":"10.3390\/jcm11206219","article-title":"Diagnosing hemophagocytic lymphohistiocytosis with machine learning: a proof of concept","volume":"11","author":"El Jammal","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jtauto.2026.100365_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cell.2020.03.022","article-title":"How machine learning will transform biomedicine","volume":"181","author":"Goecks","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jtauto.2026.100365_bib11","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/ard-2023-224123","article-title":"The 2022 EULAR\/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis\/macrophage activation syndrome (HLH\/MAS)","volume":"82","author":"Shakoory","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2026.100365_bib12","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jtauto.2026.100365_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1182\/asheducation-2009.1.127","article-title":"Hemophagocytic lymphohistiocytosis (HLH) and related disorders","author":"Filipovich","year":"2009","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtauto.2026.100365_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jtauto.2026.100365_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jclinepi.2016.11.017","article-title":"The number of primary events per variable affects estimation of the subdistribution hazard competing risks model","volume":"83","author":"Austin","year":"2017","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jtauto.2026.100365_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1389710","article-title":"Heterogeneity of macrophage activation syndrome and treatment progression","volume":"15","author":"Dong","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2026.100365_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112810","article-title":"Adult-onset still's Disease-A complex disease, a challenging treatment","volume":"23","author":"Macovei","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtauto.2026.100365_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41584-022-00899-w","article-title":"Ferritin-induced NETs lead to cytokine storm in AOSD","volume":"19","author":"Onuora","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jtauto.2026.100365_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","article-title":"The immunology of macrophage activation syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2026.100365_bib20","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/1744666X.2015.1058159","article-title":"Clinical features and correct diagnosis of macrophage activation syndrome","volume":"11","author":"Cron","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jtauto.2026.100365_bib21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/acr2.11048","article-title":"Ferritin to erythrocyte sedimentation rate ratio: simple measure to identify macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"1","author":"Eloseily","year":"2019","journal-title":"ACR Open Rheumatol"},{"issue":"Suppl 121","key":"10.1016\/j.jtauto.2026.100365_bib22","first-page":"67","article-title":"The levels of CXCL12 and its receptor, CXCR4, as a biomarker of disease activity and cutaneous manifestation in adult-onset still's disease","volume":"37","author":"Han","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jtauto.2026.100365_bib23","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jtauto.2026.100365_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.autrev.2015.01.004","article-title":"Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset still's disease, developing macrophage activation syndrome, correlate with the severity of the disease","volume":"14","author":"Ruscitti","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2026.100365_bib25","article-title":"CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis","author":"Rocco","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.jtauto.2026.100365_bib26","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","volume":"131","author":"Weiss","year":"2018","journal-title":"Blood"}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909026000183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909026000183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:25:59Z","timestamp":1781659559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909026000183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":26,"alternative-id":["S2589909026000183"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100365","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Machine learning for predicting macrophage activation syndrome in adult patients with Still's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100365"}}